Institution · Providence Health & Services
Most cited papers from Providence Health & Services
What are the most cited papers from Providence Health & Services?
The most cited paper from Providence Health & Services is "Improved Survival with Ipilimumab in Patients with Metastatic Melanoma" (Frank Stephen Hodi et al., 2010), with 15,337 citations. Next come "PD-1 Blockade in Tumors with Mismatch-Repair Deficiency" (9,595) and "Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade" (6,813).
Showing 50 of 59 papers. Every paper with more than 1,034 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Improved Survival with Ipilimumab in Patients with Metastatic Melanoma Frank Stephen Hodi et al. · New England Journal of Medicine | 5 Jun 2010 | 15,337 |
| 2 | PD-1 Blockade in Tumors with Mismatch-Repair Deficiency Dung Thi Le et al. · New England Journal of Medicine | 30 May 2015 | 9,595 |
| 3 | Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade Dung Thi Le et al. · Science | 27 Jul 2017 | 6,813 |
| 4 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky et al. · Autophagy | 2 Jan 2016 | 6,023 |
| 5 | The Somatic Genomic Landscape of Glioblastoma Cameron Brennan et al. · Cell | Oct 2013 | 5,261 |
| 6 | Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America Helen W. Boucher, George H. Talbot, John S. Bradley et al. · Clinical Infectious Diseases | 26 Nov 2008 | 5,020 |
| 7 | Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma Donald L. Morton · Archives of Surgery | Apr 1992 | 4,420 |
| 8 | Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial Anthony B. El-Khoueiry et al. · The Lancet | 20 Apr 2017 | 4,384 |
| 9 | Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease Gilbert S. Omenn, Gary E. Goodman, Mark D. Thornquist et al. · New England Journal of Medicine | 2 May 1996 | 3,667 |
| 10 | Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis Armando E. Giuliano · JAMA | 8 Feb 2011 | 2,968 |
| 11 | Cell-free nucleic acids as biomarkers in cancer patients Heidi Schwarzenbach, Dave S.�B. Hoon, Klaus Pantel · Nature reviews. Cancer | 12 May 2011 | 2,936 |
| 12 | Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer Armando E. Giuliano, Daniel M. Kirgan, Julia Guenther et al. · Annals of Surgery | Sep 1994 | 2,923 |
| 13 | Diabetic Kidney Disease Radica Z. Alicic, Michele T. Rooney, Katherine R. Tuttle · Clinical Journal of the American Society of Nephrology | 18 May 2017 | 2,905 |
| 14 | Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer Gϋnter von Minckwitz et al. · New England Journal of Medicine | 5 Dec 2018 | 2,689 |
| 15 | A Landscape of Driver Mutations in Melanoma Eran Hodis et al. · Cell | Jul 2012 | 2,672 |
| 16 | Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab Nadeem Riaz et al. · Cell | 13 Oct 2017 | 2,629 |
| 17 | International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project José Villar, Leila Cheikh Ismail, Cesar Gomes Victora et al. · The Lancet | Sep 2014 | 2,352 |
| 18 | Olaparib for Metastatic Castration-Resistant Prostate Cancer Johann Sebastian De Bono, Joaquı́n Mateo, Karim S. Fizazi et al. · New England Journal of Medicine | 28 Apr 2020 | 2,322 |
| 19 | International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study Franck Pagès et al. · The Lancet | May 2018 | 2,133 |
| 20 | Conserved cell types with divergent features in human versus mouse cortex Rebecca D. Hodge et al. · Nature | 21 Aug 2019 | 2,001 |
| 21 | Effect of Risedronate on the Risk of Hip Fracture in Elderly Women Michael R. McClung, Piet Geusens, Paul D. Miller et al. · New England Journal of Medicine | Feb 2001 | 1,931 |
| 22 | Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia Andrew Warwick Roberts, Matthew Steven Davids, John M. Pagel et al. · New England Journal of Medicine | 6 Dec 2015 | 1,929 |
| 23 | Sustainable data analysis with Snakemake Felix Mölder, Kim Philipp Jablonski, Brice Letcher et al. · F1000Research | 19 Apr 2021 | 1,847 |
| 24 | Sentinel-Node Biopsy or Nodal Observation in Melanoma Donald L. Morton, John F. Thompson, Alistair J. Cochran et al. · New England Journal of Medicine | 27 Sep 2006 | 1,840 |
| 25 | A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer Paul Edward Goss, James N. Ingle, Silvana Martino et al. · New England Journal of Medicine | 6 Nov 2003 | 1,833 |
| 26 | Vitamin E and the Risk of Prostate Cancer Eric A. Klein et al. · JAMA | 12 Oct 2011 | 1,772 |
| 27 | Bone-Marrow Transplantation E. Donnall Thomas, Rainer Storb, Clift Ra et al. · New England Journal of Medicine | 17 Apr 1975 | 1,717 |
| 28 | The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America Brad J. Spellberg, R. Guidos, David N. Gilbert et al. · Clinical Infectious Diseases | 7 Dec 2007 | 1,667 |
| 29 | Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study Ghassan K. Abou‐Alfa, Vaibhav Sahai, Antoine Hollebecque et al. · The Lancet Oncology | 20 Mar 2020 | 1,634 |
| 30 | Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma Donald L. Morton, John F. Thompson, Alistair J. Cochran et al. · New England Journal of Medicine | 12 Feb 2014 | 1,490 |
| 31 | Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies Jarushka Naidoo, David B. Page, Bob T. Li et al. · Annals of Oncology | 14 Sep 2015 | 1,479 |
| 32 | Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial Naiyer A. Rizvi et al. · The Lancet Oncology | 19 Feb 2015 | 1,436 |
| 33 | Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma Mark B. Faries et al. · New England Journal of Medicine | 7 Jun 2017 | 1,415 |
| 34 | Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease? Richard J. Johnson, Duk‐Hee Kang, Daniel I. Feig et al. · Hypertension | 21 Apr 2003 | 1,374 |
| 35 | Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours Jérôme Galon et al. · The Journal of Pathology | 11 Oct 2013 | 1,370 |
| 36 | Kidney Disease and Increased Mortality Risk in Type 2 Diabetes Maryam Afkarian, Michael Charles Sachs, Bryan R. Kestenbaum et al. · Journal of the American Society of Nephrology | 29 Jan 2013 | 1,310 |
| 37 | Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases Armando E. Giuliano, Linda Mackie McCall, Peter D. Beitsch et al. · Annals of Surgery | 25 Aug 2010 | 1,266 |
| 38 | Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma Roger Stupp et al. · JAMA | 15 Dec 2015 | 1,256 |
| 39 | Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force Heidi D Nelson, Kari Tyne, Arpana M. Naik et al. · Annals of Internal Medicine | 17 Nov 2009 | 1,254 |
| 40 | Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures Anthony P. Furnary, Kathryn J Zerr, Gary L. Grunkemeier et al. · The Annals of Thoracic Surgery | Feb 1999 | 1,247 |
| 41 | Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality Eamon Dolan, Alice V. Stanton, Lutgarde Thijs et al. · Hypertension | 7 Jun 2005 | 1,239 |
| 42 | Multiple early factors anticipate post-acute COVID-19 sequelae Yapeng Su et al. · Cell | 25 Jan 2022 | 1,238 |
| 43 | Denosumab in Postmenopausal Women with Low Bone Mineral Density Michael R. McClung, E. Michael Lewiecki, Stanley B. Cohen et al. · New England Journal of Medicine | 22 Feb 2006 | 1,225 |
| 44 | The Oregon Experiment — Effects of Medicaid on Clinical Outcomes Katherine Baicker, Sarah L. Taubman, HEIDI L. ALLEN et al. · New England Journal of Medicine | 2 May 2013 | 1,163 |
| 45 | Development and Validation of the American Heart Association’s PREVENT Equations Sadiya S. Khan et al. · Circulation | 10 Nov 2023 | 1,154 |
| 46 | Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting Anthony P. Furnary, Guangqiang Gao, Gary L. Grunkemeier et al. · Journal of Thoracic and Cardiovascular Surgery | May 2003 | 1,139 |
| 47 | A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis Frederik Nevens et al. · New England Journal of Medicine | 17 Aug 2016 | 1,137 |
| 48 | Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 Paul Edward Goss, James N. Ingle, Silvana Martino et al. · JNCI Journal of the National Cancer Institute | 6 Sep 2005 | 1,124 |
| 49 | Association of the Extent of Resection With Survival in Glioblastoma Timothy J. Brown, Matthew Brennan, Michael Jonathan Li et al. · JAMA Oncology | 16 Jun 2016 | 1,110 |
| 50 | Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America George H. Talbot, John S. Bradley, John Ernest Edwards et al. · Clinical Infectious Diseases | Feb 2006 | 1,109 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.